Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.
about
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentDisturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric SymptomsChronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistenceHIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbiditiesPlasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to TreatmentInteractions between ageing and NeuroAIDS.Understanding the MIND phenotype: macrophage/microglia inflammation in neurocognitive disorders related to human immunodeficiency virus infection.MSM ameliorates HIV-1 Tat induced neuronal oxidative stress via rebalance of the glutathione cycleAnemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy EraNeuroprotective effects of tetrandrine against vascular dementia.Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders.Application of "Omics" Technologies for Diagnosis and Pathogenesis of Neurological Infections.Tat-Mediated Induction of miRs-34a & -138 Promotes Astrocytic Activation via Downregulation of SIRT1: Implications for Aging in HAND.Degradation of heme oxygenase-1 by the immunoproteasome in astrocytes: A potential interferon-γ-dependent mechanism contributing to HIV neuropathogenesis.Fate of microglia during HIV-1 infection: From activation to senescence?Laboratory Diagnosis of Central Nervous System Infection.Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics.Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation.Changing clinical phenotypes of HIV-associated neurocognitive disorders.N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders.Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients.Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.The effects of HIV and aging on subcortical shape alterations: A 3D morphometric study.HIV/HAART-associated oxidative stress is detectable by metabonomics.Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study.Redefining Aging in HIV Infection Using Phenotypes.Metabolic Profiling of Impaired Cognitive Function in Patients Receiving Dialysis.In vitro modeling of HIV proviral activity in microglia.Lymphocyte-Dominant Encephalitis and Meningitis in Simian Immunodeficiency Virus-Infected Macaques Receiving Antiretroviral Therapy.Longitudinal Metabolite Profiling of Cerebrospinal Fluid in Normal Pressure Hydrocephalus Links Brain Metabolism with Exercise-Induced VEGF Production and Clinical Outcome.Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy
P2860
Q26766448-72C6097C-7645-47E8-B365-934D322E44B3Q26800052-CCDB518E-5FBA-49BD-8F4B-BD7B70FDC416Q26825762-3F3763B5-7587-49D9-A331-21FA31290153Q27015965-5EBF4E57-402E-4CE5-A0FB-49E5F7146DAFQ28587923-0AE13889-0D5C-425C-B1B2-2E660B7564C6Q34977613-38D3E9F2-5F42-4FE3-BCA8-EC1CCC2971EBQ35264787-7306DADD-0775-4AD4-B384-8414131BF3A5Q35440147-7C67B1E4-44A1-442E-B99D-239CCC6FB381Q36654580-0DB67677-3F3A-4FCC-BF1D-BBA3CF305CA5Q36790852-8DB1F484-DE31-4E71-84F6-A5F7B9ABB19FQ36989549-99C6E8F2-5C4F-4597-9CAA-EE1ECEA7AEF3Q38551782-D25E30E0-B645-4D2D-AE99-2AE29E0A55FEQ38714925-D4283736-14A9-4BAD-AE2B-301796A1D757Q38764320-9DD93FEF-4874-490C-9AB7-5A7AA4774FAFQ38790617-CC9A45EB-FC64-4654-8089-3585C3FD899DQ38816317-A9C97BA4-D2EE-4207-B298-DC675AC633D2Q38882614-E9C02C97-1CAC-4860-A361-874322F84455Q40050469-F626A4BB-F159-4E66-A166-F8F89EBA1E54Q40104529-3147C613-148F-4F69-A995-AABFE543461BQ40113255-0DCA74ED-DD2B-4C53-8584-555CD2FD46A0Q40175740-BD243E53-6A4F-4A78-9EDC-AE44E510EB03Q40437527-35748F1D-5909-4BB5-A94A-5E8FD8A23696Q40486706-14AA0315-3775-4061-9724-CFDE327D2768Q41935715-54C1B364-F77B-4BB6-9F3D-25FAACFC1551Q41991842-3FE15F86-5F13-44E2-96C0-30D021B023DBQ42364515-132132D5-B596-45D1-AE68-51C653A1F1ECQ46231230-51D9156F-807A-4EC1-86C6-CBFFB24FCE7AQ47427869-9D2C5AC2-E752-467E-B479-114B833C0B02Q47566977-92A39A3C-09EB-49FB-A240-253F390F5EA9Q52139716-957BCA25-CB03-4AE5-BABD-EE4021CAC201Q58549748-6F1F06C1-E38C-4411-8F93-BF2B939564AD
P2860
Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cerebrospinal fluid metabolomi ...... ith neurocognitive impairment.
@ast
Cerebrospinal fluid metabolomi ...... ith neurocognitive impairment.
@en
type
label
Cerebrospinal fluid metabolomi ...... ith neurocognitive impairment.
@ast
Cerebrospinal fluid metabolomi ...... ith neurocognitive impairment.
@en
prefLabel
Cerebrospinal fluid metabolomi ...... ith neurocognitive impairment.
@ast
Cerebrospinal fluid metabolomi ...... ith neurocognitive impairment.
@en
P2093
P2860
P1433
P1476
Cerebrospinal fluid metabolomi ...... ith neurocognitive impairment.
@en
P2093
Anupriya Dutta
Dana Gabuzda
Edana Cassol
Vikas Misra
P2860
P304
P356
10.1097/QAD.0000000000000303
P407
P577
2014-07-01T00:00:00Z